Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Ingredion Inc. (INGR) Stock Forecast & Price Prediction United States | NYSE | Consumer Defensive | Packaged Foods
$114.21
-1.04 (-0.90%)Did INGR Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Ingredion is one of their latest high-conviction picks.
Based on our analysis of 12 Wall Street analysts, INGR has a neutral consensus with a median price target of $128.00 (ranging from $120.00 to $140.00). The overall analyst rating is Buy (7.4/10). Currently trading at $114.21, the median forecast implies a 12.1% upside. This outlook is supported by 3 Buy, 4 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Pooran Sharma at Stephens & Co., suggesting a 5.1% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for INGR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 9, 2026 | UBS | Joshua Spector | Neutral | Maintains | $122.00 |
| Mar 17, 2026 | Benchmark | Ben Klieve | Buy | Initiates | $130.00 |
| Feb 5, 2026 | UBS | Joshua Spector | Neutral | Maintains | $124.00 |
| Feb 4, 2026 | Barclays | Benjamin Theurer | Equal-Weight | Maintains | $128.00 |
| Feb 4, 2026 | Stephens & Co. | Pooran Sharma | Equal-Weight | Reiterates | $120.00 |
| Nov 6, 2025 | Barclays | Benjamin Theurer | Equal-Weight | Downgrade | $124.00 |
| Nov 5, 2025 | BMO Capital | Andrew Strelzik | Market Perform | Maintains | $123.00 |
| Nov 5, 2025 | Stephens & Co. | Pooran Sharma | Equal-Weight | Maintains | $120.00 |
| Nov 5, 2025 | UBS | Joshua Spector | Neutral | Maintains | $119.00 |
| Oct 6, 2025 | UBS | Joshua Spector | Neutral | Maintains | $130.00 |
| Jul 9, 2025 | UBS | Cody Ross | Neutral | Maintains | $151.00 |
| Apr 22, 2025 | Oppenheimer | Kristen Owen | Outperform | Maintains | $155.00 |
| Apr 7, 2025 | UBS | Cody Ross | Neutral | Downgrade | $145.00 |
| Feb 5, 2025 | Oppenheimer | Kristen Owen | Outperform | Maintains | $167.00 |
| Feb 5, 2025 | Stephens & Co. | Ben Bienvenu | Equal-Weight | Maintains | $150.00 |
| Feb 5, 2025 | BMO Capital | Andrew Strelzik | Market Perform | Maintains | $133.00 |
| Nov 15, 2024 | UBS | Cody Ross | Buy | Maintains | $173.00 |
| Nov 6, 2024 | BMO Capital | Andrew Strelzik | Market Perform | Maintains | $147.00 |
| Nov 6, 2024 | Barclays | Benjamin Theurer | Overweight | Maintains | $168.00 |
| Nov 6, 2024 | Oppenheimer | Kristen Owen | Outperform | Maintains | $178.00 |
The following stocks are similar to Ingredion based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Ingredion Inc. has a market capitalization of $7.20B with a P/E ratio of 10.3x. The company generates $7.22B in trailing twelve-month revenue with a 10.1% profit margin.
Revenue growth is -2.4% quarter-over-quarter, while maintaining an operating margin of +13.3% and return on equity of +18.1%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Produces starches and sweeteners from raw materials.
The company generates revenue by supplying a diverse range of ingredients, including sweeteners and starches, to various industries such as food and beverage, pharmaceuticals, and brewing. Its focus on clean label and non-GMO products enables it to meet consumer demand for healthier and more sustainable options.
Ingredion operates globally, impacting food manufacturers and consumers with its innovative solutions. The company is positioned well within the trends of health-conscious and environmentally friendly ingredients, ensuring its relevance in a rapidly changing market.
Consumer Defensive
Packaged Foods
11,000
Mr. James P. Zallie
United States
1997
Ingredion Incorporated (NYSE: INGR) will release its Q1 2026 financial results on May 5, 2026, before market opening.
Ingredion's upcoming Q1 2026 financial results will provide insights into its performance, affecting stock valuation and market sentiment within the food manufacturing sector.
Ingredion Incorporated announced the retirement of board member Gregory B. Kenny and the appointment of Siobhรกn Talbot to its board, effective April 1, 2026.
Board changes can signal shifts in company strategy or governance. The appointment of a new member like Siobhรกn Talbot may bring fresh perspectives, impacting investor confidence and future performance.
Ingredion Incorporated (NYSE: INGR) has declared a quarterly dividend of $0.82 per share on its common stock, effective March 18, 2026.
A quarterly dividend of $0.82 per share signals financial stability and profitability for Ingredion, potentially attracting income-focused investors and boosting share price.
Ingredion has been recognized as one of Ethisphere's 2026 World's Most Ethical Companies for the 12th time, highlighting its commitment to ethics, compliance, and governance.
Ingredion's recognition for strong ethics enhances its reputation, potentially attracting socially conscious investors and boosting long-term stability and trust in its brand.
Shiru and Ingredion are collaborating to use AI and formulation expertise to expedite the market introduction of next-generation natural prebiotics.
The collaboration enhances product development speed and innovation in the growing prebiotics market, potentially increasing revenue and market share for both companies.
ADM, BYND, and INGR are shifting from traditional commodity models in AgTech & Food Innovation, leveraging science and technology for higher-value growth opportunities.
ADM, BYND, and INGR's shift to innovative, tech-driven approaches signals potential for higher returns, attracting investment interest and reshaping market dynamics in AgTech.
Based on our analysis of 12 Wall Street analysts, Ingredion Inc. (INGR) has a median price target of $128.00. The highest price target is $140.00 and the lowest is $120.00.
According to current analyst ratings, INGR has 3 Buy ratings, 4 Hold ratings, and 0 Sell ratings. The stock is currently trading at $114.21. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict INGR stock could reach $128.00 in the next 12 months. This represents a 12.1% increase from the current price of $114.21. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue by supplying a diverse range of ingredients, including sweeteners and starches, to various industries such as food and beverage, pharmaceuticals, and brewing. Its focus on clean label and non-GMO products enables it to meet consumer demand for healthier and more sustainable options.
Price targets from Wall Street analysts for INGR are not currently available. The stock is trading at $114.21.
The lowest price target for INGR is $120.00 from Pooran Sharma at Stephens & Co., which represents a 5.1% increase from the current price of $114.21.
The overall analyst consensus for INGR is neutral. Out of 12 Wall Street analysts, 3 rate it as Buy, 4 as Hold, and 0 as Sell, with a median price target of $128.00.
Stock price projections, including those for Ingredion Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.